Owner Medarex, Inc.

Inventors Guerlavais, Vincent; Gangwar, Sanjeev; Horgan, Kilian; Sufi, Bilal; Li, Zhi-Hong; Boyd, Sharon; Chen, Liang

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005244980

PCT Pub. Number WO2005/112919

Priority 60/661,174 09.03.05 US; 60/572,667 19.05.04 US; 60/669,871 08.04.05 US

Filing date 19 May 2005

Wipo publication date 1 December 2005

Acceptance publication date 15 September 2011

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/18 (2006.01) Preparations for testing

A61P 35/00 (2006.01) Antineoplastic agents

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups